Skip to main content

Table 2 Local anesthetic consumption

From: Programmed intermittent epidural bolus versus continuous epidural infusion for postoperative analgesia after major abdominal and gynecological cancer surgery: a randomized, triple-blinded clinical trial

 

Group CEI (n = 40)

Group PIEB (n = 44)

p-value

HL-Estimator (95% CI)

LA PCA Bolus d0-d2, ml

28 (12–64)

10 (2–28)

0.002*

16 (4; 28)

LA PIEB/CEI amount d0-d2, ml

323.5(286.6–336.7)

311.4 (263–330.2)

0.161

10.2 (−4; 30.6)

Overall LA consumption d0-d2, ml

350.3 (326.5–380.8)

329 (291–341.1)

0.003

29.55 (10.7;52.1)

LA PCA Bolus d0, ml

0 (0–8)

0 (0–4)

0.046

0 (0; 0)

LA PCA Bolus d1, ml

18 (4–26)

4 (0–14)

0.002*

8 (4; 16)

LA PCA Bolus d2, ml

12 (4–34)

4 (0–12)

0.010*

4 (0; 12)

LA PIEB/CEI amount d0, ml

50.9 (36–55.7)

48 (36–54)

0.238

2.9 (−1,8; 6.8)

LA PIEB/CEI amount d1, ml

140.9 (132.4–145.2)

132.3 (120–141.7)

0.015*

8.3 (1.2; 17.2)

LA PIEB/CEI amount d2, ml

135.2 (110.6–141.4)

131 (109.5–140.1)

0.588

2.3 (−6.6; 11)

  1. LA local anesthestic, d0 day of operation; d1/d2 first/second postoperative day; PIEB programmed intermittent epidural bolus, CEI continuous epidural infusion, PCA patient controlled bolus, HL Hodges-Lehman. Values are expressed as the median (25th–75th percentiles), Mann-Whitney-U-Testing, two-sided p-value. Uncorrected p-values are displayed. Level of significance p < 0.05. *, significant